News & Breakthroughs
Read the latest news from Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute. The links below take you to articles where you can learn more about our latest events and accomplishments.
For weekly updates on research breakthroughs, events, and more, sign up to receive our weekly newsletter by emailing MBTI@nm.org.
10.03.2025Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma — the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD, shares promising research on the potential benefits of immunotherapy for certain glioblastoma patients.
10.03.2025Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway.
10.03.2025Daniel Brat, MD, PhD, is spearheading the evolution toward precision medicine within the arena of brain tumor diagnostics.
10.03.2025Man’s best friend is helping scientists find new treatments for brain tumors. Amy Heimberger, MD, is a board-certified neurosurgeon with extensive training and experience in the field of immunology. She is part of a promising new study in canine glioblastoma that could lead to more effective human glioblastoma clinical trials.
06.26.2025A drug commonly used to treat diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which could help treat the disease less invasively than current treatments, according to a study published in the Journal of Clinical Investigation.
06.09.2025Feng Yue, PhD, the Duane and Susan Burnham Professor of Molecular Medicine in the Department of Biochemistry and Molecular Genetics, has been inducted into the 2025 class of American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
05.30.2025Genetic makeup and structure can shift dramatically across different areas of a single glioblastoma tumor, reveals a Northwestern Medicine study published in Science Advances.
03.27.2025Cell death has been found to be a driving factor in glioblastoma progression, according to a Northwestern-Medicine-led study published in the Proceedings of the National Academy of Sciences.
02.24.2025Northwestern Medicine investigators have discovered unique genetic and structural changes in endothelial cells in the brain after disrupting the blood-brain barrier, which may inform new therapeutic targets that promote blood-brain barrier repair after neurovascular injuries, according to a recent study.
11.20.2024Patients with a subtype of glioblastoma who received a combination treatment of a PARP inhibitor and standard chemotherapy did not demonstrate improved survival compared to chemotherapy and placebo, according to a recent clinical trial published in JAMA Oncology.